Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Cytochrome P450 (CYP) monooxygenases catalyze the oxidation of a large number of endogenous compounds and the majority of ingested environmental chemicals, leading to their elimination and often to their metabolic activation to toxic products. This enzyme system therefore provides our primary defense against xenobiotics and is a major determinant in the therapeutic efficacy of pharmacological agents. To evaluate the importance of hepatic P450s in normal homeostasis, drug pharmacology, and chemical toxicity, we have conditionally deleted the essential electron transfer protein, NADH:ferrihemoprotein reductase (EC, cytochrome P450 reductase, CPR) in the liver, resulting in essentially complete ablation of hepatic microsomal P450 activity. Hepatic CPR-null mice could no longer break down cholesterol because of their inability to produce bile acids, and whereas hepatic lipid levels were significantly increased, circulating levels of cholesterol and triglycerides were severely reduced. Loss of hepatic P450 activity resulted in a 5-fold increase in P450 protein, indicating the existence of a negative feedback pathway regulating P450 expression. Profound changes in the in vivo metabolism of pentobarbital and acetaminophen indicated that extrahepatic metabolism does not play a major role in the disposition of these compounds. Hepatic CPR-null mice developed normally and were able to breed, indicating that hepatic microsomal P450-mediated steroid hormone metabolism is not essential for fertility, demonstrating that a major evolutionary role for hepatic P450s is to protect mammals from their environment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these mice had hepatomegaly, accumulated hepatic lipids, and had a 99% decrease in bile acids, 65% decrease in serum cholesterol, and 50% decrease in serum triglycerides.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
In the citing paper
“By contrast, liver-specific POR knockout mice created by cre/lox technology were grossly normal-developing, growing, and living as long as normal mice, and having normal reproductive capacity, indicating normal gonadal P450 function (312,313).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
In the citing paper
“Furthermore these animals had dramatically decreased capacities to metabolize acetaminophen, phenobarbital, and testosterone despite having a 5-fold increase in total hepatic P450 content.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
In the citing paper
“Liver-specific knockout of POR in mice decreases the activities of hepatic drug-metabolizing enzymes (312, 313), thereby potentially rendering some drugs teratogenic.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [312]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Conney, A. H. (1982) · PubMed · Cited by 1,557
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Self-citationHayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 816
The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis
Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 759
Role of CYP2E1 in the Hepatotoxicity of Acetaminophen
Lee, S. S. T., Buters, J. T. M., Pineau, T., Fernandez-Salguero, P., & Gonzalez, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.12063 · Cited by 656
Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat
Spady, D. K., & Dietschy, J. M. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37999-2 · Cited by 411
Tzameli, I., Pissios, P., Schuetz, E. G., & Moore, D. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2951-2958.2000 · Cited by 408
Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR
Zhang, J., Huang, W., Chua, S. S., Wei, P., & Moore, D. D. (2002) · Science · doi:10.1126/science.1073502 · Cited by 316
Bosner, M. S., Lange, L. G., Stenson, W. F., & Ostlund, R. E. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33370-8 · Cited by 310
The cytochrome P450 4 (CYP4) family
Simpson, A. E. C. M. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00246-7 · Cited by 298
Forty Years of Cytochrome P450
Omura, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1887 · Cited by 270
Disruption of Cholesterol 7α-Hydroxylase Gene in Mice
Schwarz, M., Lund, E. G., Setchell, K. D. R., Kayden, H. J., Zerwekh, J. E., Björkhem, I., Herz, J., & Russell, D. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18024 · Cited by 270
Oxygen and Xenobiotic Reductase Activities of Cytochrome P450
Goeptar, A. R., Scheerens, H., & Vermeulen, N. P. E. (1995) · Critical Reviews in Toxicology · doi:10.3109/10408449509089886 · Cited by 261
Schwarz, M., Russell, D. W., Dietschy, J. M., & Turley, S. D. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32171-4 · Cited by 258
Sen, C. K., Marin, E., Kretzschmar, M., & Hanninen, O. (1992) · Journal of Applied Physiology · doi:10.1152/jappl.1992.73.4.1265 · Cited by 249
Disruption of the Oxysterol 7α-Hydroxylase Gene in Mice
Li-Hawkins, J., Lund, E. G., Turley, S. D., & Russell, D. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001811200 · Cited by 246
Disruption of Cholesterol 7α-Hydroxylase Gene in Mice
Ishibashi, S., Schwarz, M., Frykman, P. K., Herz, J., & Russell, D. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18017 · Cited by 237
Forrester, L. M., Henderson, C. J., Glancey, M. J., Back, D. J., Park, B. K., Ball, S. E., Kitteringham, N. R., McLaren, A. W., Miles, J. S., Skett, P., et al. (1992) · Biochemical Journal · doi:10.1042/bj2810359 · Cited by 233
Self-citationZonation of hepatic cytochrome P-450 expression and regulation
OINONEN, T., & LINDROS, O. K. (1998) · Biochemical Journal · doi:10.1042/bj3290017 · Cited by 227
Shen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S -transferase Pi
Henderson, C. J., Wolf, C. R., Kitteringham, N., Powell, H., Otto, D., & Park, B. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220176997 · Cited by 222
Self-citationJover, R. (2001) · Hepatology · doi:10.1053/jhep.2001.22176 · Cited by 216
Coles, B., Wilson, I., Wardman, P., Hinson, J. A., Nelson, S. D., & Ketterer, B. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90592-9 · Cited by 205
Repa, J. J., Lund, E. G., Horton, J. D., Leitersdorf, E., Russell, D. W., Dietschy, J. M., & Turley, S. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007653200 · Cited by 202
Strömstedt, M., Rozman, D., & Waterman, M. R. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0193 · Cited by 162
Wolf, C. R., Moll, E., Friedberg, T., Oesch, F., Buchmann, A., Kuhlmann, W. D., & Kunz, H. W. (1984) · Carcinogenesis · doi:10.1093/carcin/5.8.993 · Cited by 149
Self-citationDissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.
Smith, G. C., Tew, D. G., & Wolf, C. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8710 · Cited by 136
Self-citationConditional Gene Knockout Using Cre Recombinase
Le, Y.-Z., & Sauer, B. (2001) · Molecular Biotechnology · doi:10.1385/mb:17:3:269 · Cited by 126
Role of CYP1A2 in the Hepatotoxicity of Acetaminophen: Investigations UsingCyp1a2Null Mice
Tonge, R. P., Kelly, E. J., Bruschi, S. A., Kalhorn, T. F., Eaton, D. L., Nebert, D. W., & Nelson, S. D. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8543 · Cited by 113
Sex-specific, growth hormone-regulated transcription of the cytochrome P450 2C11 and 2C12 genes.
Sundseth, S. S., Alberta, J. A., & Waxman, D. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50612-3 · Cited by 111
Cholesterol and hepatic lipoprotein assembly and secretion
Kang, S., & Davis, R. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00151-7 · Cited by 103
Characterization of the Human Cytochrome P4502D6 Promoter
Cairns, W., Smith, C. D., McLaren, A. W., & Wolf, C. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25269 · Cited by 94
Self-citationLamb, D. C., Kelly, D. E., Manning, N. J., Kaderbhai, M. A., & Kelly, S. L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01548-3 · Cited by 91
Cytochrome P-450s: polymorphic multigene families involved in carcinogen activation
Wolf, C. R. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90232-5 · Cited by 85
Self-citationMeehan, R. R., Forrester, L. M., Stevenson, K., Hastie, N. D., Buchmann, A., Kunz, H. W., & Wolf, C. R. (1988) · Biochemical Journal · doi:10.1042/bj2540789 · Cited by 76
Self-citationGenetic Variation in Cholesterol Absorption Efficiency among Inbred Strains of Mice , ,
Carter, C. P., Howles, P. N., & Hui, D. Y. (1997) · Journal of Nutrition · doi:10.1093/jn/127.7.1344 · Cited by 74
Shapiro, B. H., MacLeod, J. N., Pampori, N. A., Morrissey, J. J., Lapenson, D. P., & Waxman, D. J. (1989) · Endocrinology · doi:10.1210/endo-125-6-2935 · Cited by 69
Recent advances in P450 research
Raucy, J. L., & Allen, S. W. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500044 · Cited by 57
Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes
Henderson, C. J., Scott, A. R., Yang, C. S., & Wolf, C. R. (1990) · Biochemical Journal · doi:10.1042/bj2660675 · Cited by 54
Self-citationEffects of Human Cytochrome b5on CYP3A4 Activity and Stabilityin Vivo
Voice, M. W., Zhang, Y., Wolf, C. R., Burchell, B., & Friedberg, T. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1192 · Cited by 52
Self-citationDietschy, J. M., Spady, D. K., & Stange, E. F. (1983) · Biochemical Society Transactions · doi:10.1042/bst0110639 · Cited by 45
Smith, G. C., Henderson, C. J., Parker, M. G., White, R., Bars, R., & Wolf, C. R. (1993) · Biochemical Journal · doi:10.1042/bj2890807 · Cited by 43
Self-citationAn old activity in the cytochrome P450 superfamily (CYP51) and a new story of drugs and resistance
Kelly, S. L., Lamb, D. C., Cannieux, M., Greetham, D., Jackson, C. J., Marczylo, T. H., Ugochukwu, C. C., & Kelly, D. E. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290122 · Cited by 41
An old activity in the cytochrome P450 superfamily (CYP51) and a new story of drugs and resistance
Kelly, S. L., Lamb, D. C., Cannieux, M., et al. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290122 · Cited by 39
Hines, R. N., Luo, Z., Cresteil, T., Ding, X., Prough, R. A., Fitzpatrick, J. L., Ripp, S. L., Falkner, K. C., Ge, N. L., Levine, A., et al. (2001) · PubMed · Cited by 28
Cytochromes P450 in synthesis of steroid hormones, bile acids, vitamin D3 and cholesterol.
Pikuleva, I. A., & Waterman, M. R. (1999) · PubMed · Cited by 25
Immunodetection of Proteins by Western Blotting
Henderson, C. J., & Wolf, C. R. (2003) · Humana Press eBooks · doi:10.1385/0-89603-204-3:221 · Cited by 23
Self-citationBrochet, D., Chermat, R., DeFeudis, F. V., & Drieu, K. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00018-x · Cited by 22
Structural studies on FMN domain of Cytochrome P450 reductase
Modi, S. P., Lian, L., Roberts, G. C. K., SMTTH, G. C. M., Paine, M. J. I., & Wolf, C. R. (1995) · Biochemical Society Transactions · doi:10.1042/bst023476s · Cited by 4
Self-citation
Research works printed but not linked: 4
- Pikuleva, 1999, Mol. Aspects Med., 20, 33
- Henderson, 1992, 10, 221
- Hines, 2001, Drug Metab. Dispos., 29, 623
- Conney, 1982, Cancer Res., 42, 4875
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
The Human Obesity Gene Map: The 2005 Update
Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G., Walts, B., Pérusse, L., & Bouchard, C. (2006) · Obesity · doi:10.1038/oby.2006.71 · Cited by 1,119
“2 POR P450 (cytochrome) oxidoreductase Conditional KO (liver specific) Increased liver weight and fatty liver (506,507)”
BackgroundCytochrome P450s and other enzymes in drug metabolism and toxicity
Guengerich, F. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080112 · Cited by 624
Oxidative Damage and Antioxidant Defense in Ferroptosis
Kuang, F., Liu, J., Tang, D., & Kang, R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.586578 · Cited by 531
“Given that the conditional knockout of POR in the liver leads to a decrease in the metabolism and lipid accumulation in mice (Henderson et al., 2003), the pathological role of POR-mediated ferroptosis in tissue damage and metabolism disease is worthy of further study.”
BackgroundGachon, F., Olela, F. F., Schaad, O., Descombes, P., & Schibler, U. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.015 · Cited by 512
“For example, a similar phenotype has been observed in mice with a liver-specific disruption of the Por gene (Gu et al., 2003; Henderson et al., 2003 ).”
Background
Metadata
- Authors
- Henderson, C. J., Otto, D. M. E., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., & Wolf, C. R.
- Affiliations
- Cancer Research UK (GB)
- Corresponding author
- Rosewell, Ian
- Wolf, C. Roland
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 15
- Pages
- 13480-13486
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047821701
- Semantic Scholar
- 23689d9cea73d2a1ad2d52b9778fe58ba7110680
- Cited by
- 258
- References
- 52
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 15 · 2014: 19 · 2013: 19 · 2012: 25
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6409 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- NADPH-cytochrome P450 reductase, conditional gene deletion, bile acid synthesis, cholesterol metabolism, acetaminophen metabolism, steroid hormone metabolism
- MeSH terms
- Acetaminophen, Animals, Cytochrome P-450 Enzyme System, Exons, Female, Glutathione, Liver, Male, Mice, Transgenic, NADPH-Ferrihemoprotein Reductase, Pentobarbital, Promoter Regions, Genetic, Serum Albumin, Sex Characteristics, Restriction Mapping, Genomic Library, Gene Deletion, Mice, Knockout, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.